KreaMedica logo

KreaMedica

North America, Quebec, Canada, Montréal

Description

KreaMedica is a drug development and consulting solutions company that provides quick access to engage with right consultants/experts.

Investor Profile

KreaMedica has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (50%)
  • Germany (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does KreaMedica frequently co-invest with?

Creative Ventures
North America, California, United States, Oakland
Co-Investments: 1
Prox Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1
HTGF | High-Tech Gruenderfonds
Europe, Nordrhein-Westfalen, Germany, Bonn
Co-Investments: 1
Meneldor
Europe, Gelderland, The Netherlands, Druten
Co-Investments: 1
Wilson Sonsini Goodrich & Rosati
North America, California, United States, Palo Alto
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Gemseki
Asia, Tokyo, Japan, Akasaka
Co-Investments: 1

Which angels does KreaMedica often collaborate with?

JB
North America, North Dakota, United States, Fargo
Shared Deals: 1

What are some of recent deals done by KreaMedica?

Cytonus Therapeutics

Carlsbad, California, United States

Cytonus is a biotech company combining AI-driven drug discovery together with a class defining drug-delivery platform called the Cargocyte

BiotechnologyHealth CareMedical
Series ANov 3, 2023
Amount Raised: $11,703,095
Atriva Therapeutics

Tübingen, Baden-Wurttemberg, Germany

Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series AJan 3, 2019